November 07, 2019
Ph.D. Student Named Finalist for INFORMS Best Student Paper
A paper co-authored by Tepper School of Business Ph.D. candidate Kyra Gan was selected by the Service Science Sector of the Institute for Operations Research and the Management Sciences as a finalist for the IBM Service Science Best Student Paper.
“Personalized Treatment for Opioid Use Disorder” — which Gan authored along with her advisers Sridhar Tayur, Ford Distinguished Research Chair, University Professor of Operations Management, and Alan Scheller-Wolf, Richard M. Cyert Professor of Operations Management, Senior Associate Dean of Faculty and Research — investigates what conditions support investing in wearable devices to treat opioid use disorder.
The student paper competition is sponsored by IBM Research, a research lab at IBM exploring advancements in AI, blockchain, and quantum computing. Winners and finalists are selected by the INFORMS Service Science Section, a branch of the operations research association dedicated to interdisciplinary study that provides value to the service sector.
Gan believes the important societal context contributed to her paper’s selection for the recognition. “Opioid use disorder is a fatal disease that is both time-consuming and expensive to treat,” Gan said. “Our paper can potentially guide policy makers and practitioners to make better decisions about whether to adopt new technology in the treatment regimen when they face limited budget.”
The researchers concluded that wearable devices can be a valuable tool for opioid use disorder when patients are generally unlikely to follow all treatment instructions and when their budgets are moderately constrained. They developed a framework to help providers develop optimal plans for patients that are adapted to their individual circumstances.
Gan presented the paper at the INFORMS Annual Meeting on Oct. 21. “Attending the annual conference provides me the opportunity for learning recent advances in the fields of operations research and management science, as well as finding collaborators and discussing my work with my peers,” she said. “I very much appreciate this experience and will do my best to contribute to the field of personalized medicine.”